It goes without saying that the primary purpose of clinical trials is to provide data that indicates which treatment provides the best outcome for patients (ideally the individual patient); and in the context of adjuvant treatment for breast cancer this means maximisation of the chance of overall survival or 'cure'. In the real world such conclusions may be difficult to reach for a variety of reasons.
|Number of pages||4|
|Journal||Translational Cancer Research|
|Publication status||Published - 1 Aug 2012|